Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study.

Details

Language :

English

ISSN :

01676997

Volume :

30

Issue :

4

Database :

Complementary Index

Journal :

Investigational New Drugs

Publication Type :

Academic Journal

Accession number :

77495414

Full Text :

https://doi.org/10.1007/s10637-011-9682-9